Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantation

Table 1 Clinical and demographic characteristics of the studied population

Recipient male gender, n (%)	63 (70.0)
Donor male gender, n (%)	53 (58.9)
Recipient age at transplantation (yr), median (range)	53 (23–66)
Donor age (yr), median (range)	41 (17–77)
Etiology of liver disease, n (%)	55 (61.1)
HCV infection	12 (13.3)
HBV infection	13 (14.5)
Alcohol abuse	10 (11.1)
Other, unknown
Child–Pugh score pre-transplantation, median (range)	8 (5–14)
Immunosuppressive regimen, n (%)	69 (76.7)
Tacrolimus-based	21 (23.3)
Cyclosporine-based	32 (58.2)
Antiviral therapy in HCV positive, n (%)

Categorical variables are expressed as frequencies (%); continuous variables as median (range). HCV: hepatitis C virus.